Join
Live feed
·
INSIDERFilingvia Quantisnow
Evelo Biosciences Inc. logo

SEC Form 4: Bodmer Mark sold $29,747 worth of shares (3,128 units at $9.51) and converted options into 6,625 shares, increasing direct ownership by 27% to 16,624 units

ByQuantisnow·Wall Street's wire, on your screen.
EVLO· Evelo Biosciences Inc.
Health Care
Original source

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track EVLO (Evelo Biosciences Inc.) and more on Quantisnow.